Log in
安信证券-血制品行业深度跟踪：年初至今批签发稳健增长，期待疫后常规需求持续回暖-230429
English body is not available for this report yet; showing the Chinese version. View in Chinese
常见问题
- 这份报告主要研究什么？
- 《安信证券-血制品行业深度跟踪：年初至今批签发稳健增长，期待疫后常规需求…》主要讨论：血制品行业深度跟踪：年初至今批签发 稳健增长，期待疫后常规需求持续回暖 目白蛋白：行业稳健增长，国产替代空间广阔。经测算，国内白蛋白的理论总年需求量为1500-1800吨，而我国白蛋白2022年批签…
- 报告来自哪个机构？何时发布？
- 来源机构：安信证券，报告发布于 2023-04-29，篇幅约 32 页。
Copyright notice
This report is aggregated from publicly available internet sources. Copyright belongs to the original authors or rights holders. If you are a rights holder and believe content on this platform infringes your rights, please email copyright@ruishubaogao.com . We will remove the content promptly after verification.